Introduction
Helicobacter pylori (H.pylori) is a fastidious gram negative bacillus that grows under microaerophilic conditions. It is a widely identified pathogen around the world and defined as an etiological agent of various gastrointestinal disorders that range from simple dyspepsia, gastric ulcer and even gastric carcinoma. WHO has classified H. pylori as a class 1 carcinogen (1). The prevalence of H. pylori infection varies according to the difference in sanitary conditions and it may exceed 70% in developing countries associated with bad sanitary conditions. Various factors are claimed to be associated with the degree of the pathogenicity of H.pylori, such as host factors, bacterial virulence genotypes and environmental factors (2) . The cagA gene, and the vacuolating cytotoxin gene (vacua) are thought to be implicated in the pathogenicity of H. pylori. CagA is encoded by the cagA gene located at one end of the cag PAI (3). The cagA gene encodes for a protein that leads a number of cellular changes. It has been reported that cagA gene is an indicator for the presence of all genes of the cagPAI including cagT, cagM and cagE,. The cagPAI family gene is responsible for type IV secretion system, which delivers CagA positive strains into the cytosol of gastric epithelial cells (4) . The cagA gene is found in high percentage of virulent H .pylori strains associated with duodenal ulcer and gastric cancer(4). The profile of cagPAI genes of H.pylori shows great variability worldwide due to insertions or deletions within the cag gene which make its study is necessary in different geographic locations.
The other virulent gene, vacA gene encodes for the vacuolating cytotoxin, the pore forming toxin which leads to gastric epithelial cell injury. The vacuolating activity in host cells varies due to mosaicism of the vacA gene in signal (s) and median (m) regions (5-7).
H.pylori clinical isolates are categorized according to the presence or absence of cagPAI ,affecting the degree of pathogenicity, into type I, associated with severe disease pathology, expresses functional vaca (vacuolating cytotoxin A) and contains the cag (cytotoxin-associated gene) pathogenicity island (cagPAI) and type II lacks cagPAI and had a nontoxic form of vaca and is regarded as less virulent (8,9).
Currently, cagA genotyping is used as markers for genomic diversity among populations (10).
The aims of the present study were to study the prevalence of cagA and vaca genes among H.pylori strains isolated from patients with upper gastrointestinal disorders requiring endoscopic examinations and to relate the presence of these virulence genes to the clinical presentations of those patients.
Materials and Methods
The study included eighty two patients complaining of upper gastrointestinal disorders requiring endoscopic examinations. The patients were recruited from Gastroenterology Surgical Center, Mansoura University, Egypt from March 2014 till October 2015. The study was approved by Mansoura Faculty of medicine medical ethical committee. Each patient signed a written approval to participate in the study.
Each patient was subjected to full medical history taking and clinical examination. Upper gastroduodenal endoscope was performed under standard recommended precautions. Biopsies were obtained from the greater curvature of the stomach about 2 cm from pylorus and from duodenal ulcer. Each biopsy was transported to the laboratory in sterile container. Biopsies were homogenized and spread over Columbia blood agar supplied with 5% sheep blood (Oxoid Columbia agar base) . Plates were incubated in a microaerophilic atmosphere (oxygen tensions 5-19% and carbon dioxide tensions 5-10%, by use of gas packs in anaerobic jar (Campy Pak; Becton Dickinson) at 37 0 C for 10 days. Identification of H. pylori was made by Gram staining of the colonies, lack of aerobic growth on blood agar plates, and testing for the presence of urease, oxidase and catalase (11).
DNA Extraction
Colonies identified as H.pylori were subjected to DNA extraction by QIAamp DNA Mini Kit (Qiagen, Germany) as manufacturer protocol. The extracted DNA was stored at -20°C until amplification.
Multiples -Polymerase chain Reaction for cagA and VanA genes
Multiplex PCR was performed to simultaneously detect cagA and VasA genes.
Primers sequences used amplifications and the produced bp were summarized in table 1 (12-14).
For amplification process 3 μl was added in 25-μl volumes containing 2.5 pmol of each primers of VAG and 10 pmol of primers of cag5c-F and cag3c-R, 0.25 mM of each deoxynucleoside triphosphate, 0.9 U of Taq DNA polymerase and 1.5 mM of MgCl 2 in standard PCR buffer (Qiagen).
Products were amplified using Perkin-Elmer 9700 thermal cycler with the following program denaturation for 3 min at 94°C, 35 cycles of sequential 1 min at 94°C-1 min at 55°C-1 min at 72°C, and finally 10 min at 72°C.
Detection was performed by gel electrophoresis 2% for 20 minutes.
Results and Discussion
The study included eighty two patients. Virulence genes vaca and caga genes are well known virulence factors in H.pylori being responsible for production of two different toxins that affect the epithelium of gastric mucosa and alter immune response resulting in severe gastric disease (24) . In vitro study has demonstrated that complete absence cagPAI was associated with lower production of interleukin 8. IL-8 is multifunctional. In addition to its potent chemotactic activity, it can induce proliferation and migration of cancer cells. In this review, we focus on recent insights into the mechanisms of IL-8 signaling associated with gastric cancer. So, gastric colonization with cagA Istrains is claimed to be a risk factor for severe gastric and duodenal diseases (25) .
From this study we can conclude that H.pylori is a common pathogen associated with upper gastrointestinal tract mainly with gastric ulcer. H.pylori strains responsible for gastric ulcer were significantly harboring the caga and vaca virulence genes. These genes may predispose to severe gastric disorders. Extended large scale studies are required to find the pathogenesis of these genes in Egyptian population.
